Measles immunisation in North America

92% of children aged 12 to 23 months in North America had received a measles vaccine in 2024.

Measure: Measles immunisation of children Unit: % of children aged 12 to 23 months Data: 1980 to 2024 Source: World Bank
North America is a group: World Bank region. The value is the aggregate published by World Bank, not an average calculated on this site.
North America, 2024 92% % of children aged 12 to 23 months
Change from 2023 0percentage points 2023: 92%
World, 2024 84% Official aggregate

Measles immunisation in North America over time

View
Places
2 selected
North America World ×

% of children aged 12 to 23 months. Source: World Bank, World Development Indicators. Gaps mean no published value; points are not joined across missing years.

Measles immunisation of children (% of children aged 12 to 23 months), 2000 to 2024
Period North AmericaWorld
2024 92% 84%
2023 92% 83%
2022 92% 84%
2021 92% 82%
2020 91% 84%
2019 90% 86%
2018 92% 86%
2017 91% 85%
2016 92% 85%
2015 92% 85%
2014 92% 84%
2013 92% 84%
2012 91% 84%
2011 92% 85%
2010 92% 84%
2009 90% 83%
2008 92% 81%
2007 92% 79%
2006 92% 79%
2005 92% 77%
2004 93% 76%
2003 93% 74%
2002 91% 72%
2001 91% 73%
2000 91% 72%

A dash means no value was published for that period.

In short

  • That is unchanged from 2023.
  • Since 2014, when it was 92%, the figure has changed by +0.2 percentage points.
  • The figure for the world in 2024 was 84%.

More for North America

All statistics for North America

Source and dates

Original producer
WHO and UNICEF estimates of national immunization coverage
Distributed by
World Bank, World Development Indicators
Dataset or series code
SH.IMM.MEAS · dataset details · view at source
Observation period
1980 to 2024 for North America
Provider update
8 October 2026
Retrieved
9 November 2026
Published here
9 November 2026
Licence
CC BY 4.0 (per series metadata)
Attribution
Source: World Bank, World Development Indicators, original data: WHO and UNICEF estimates of national immunization coverage